An open-label multicenter randomized Phase 3 study comparing then combination of DOXIL/CAELYX and YONDELIS with DOXIL/CAELYX alone in subjects with advanced relapsed ovarian cancer - Protocol ET743-OVA-301
|Effective start/end date||3/3/06 → 7/31/11|
- JOHNSON AND JOHNSON MED INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.